Detalles de la búsqueda
1.
Patient-reported outcomes in advanced NSCLC before and during the COVID-19 pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315).
Int J Cancer
; 154(11): 1967-1978, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38329180
2.
Low incidence of tumor lysis syndrome in elderly patients with chronic lymphocytic leukemia treated with venetoclax under real-world conditions: results from the prospective observational VeRVe study.
Ann Hematol
; 103(6): 2013-2020, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421404
3.
AVAiLABLE NIS - AVASTIN® in lung cancer treatment in routine oncology practice in Germany.
BMC Cancer
; 19(1): 433, 2019 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077164
4.
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in patients with non-Hodgkin lymphoma (NADIR study).
Eur J Haematol
; 102(2): 174-181, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30347466
5.
Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.
Future Oncol
; 15(23): 2699-2706, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31282758
6.
Impact of performance status and transfusion dependency on outcome of patients with myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia treated with azacitidine (PIAZA study).
Eur J Haematol
; 101(6): 766-773, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30091166
7.
Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy.
Blood
; 126(12): 1407-14, 2015 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26239087
8.
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Lancet Oncol
; 17(1): 57-66, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26655425
9.
Biosimilar Epoetin Zeta in Oncology and Haematology: Development and Experience following 6 Years of Use.
Acta Haematol
; 135(1): 44-52, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26426164
10.
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet
; 381(9873): 1203-10, 2013 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-23433739
11.
Bendamustine plus mitoxantrone for relapsed/refractory chronic lymphocytic leukaemia (CLL): results of a multicentre phase II study of the German CLL Study Group (GCLLSG).
Br J Haematol
; 158(2): 238-241, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22571691
12.
Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.
Eur J Haematol
; 88(3): 260-8, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22023452
13.
Prophylaxis of chemotherapy-induced neutropenia with lipegfilgrastim in patients with lung cancer: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 38(12): 2191-2199, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047998
14.
Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
J Bone Oncol
; 33: 100420, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35340302
15.
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Lung Cancer
; 152: 174-184, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33358484
16.
Prophylaxis of chemotherapy-induced neutropenia and febrile neutropenia with lipegfilgrastim in 2489 cancer patients: final results from the non-interventional study NADIR.
Curr Med Res Opin
; 35(7): 1127-1138, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30557099
17.
Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials.
Leuk Res
; 68: 90-97, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29579627
18.
A phase I/II trial of topotecan and radiation therapy for brain metastases in patients with solid tumors.
Int J Radiat Oncol Biol Phys
; 68(3): 839-44, 2007 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17379446
19.
High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Leuk Lymphoma
; 48(7): 1299-306, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17613757
20.
Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.
Onco Targets Ther
; 10: 1295-1305, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28280364